Ischemia Care (ISC), the parent company of Ischemic Stroke Lab, is honored to be chosen from a pool of almost 800 applicants by MedTech Innovator as one of 50 leading medtech startups transforming the healthcare industry. The ISC team is honored and excited to particip...

Ischemic Stroke Lab is pleased to announce that the Ischemia Care company laboratory has reached an important milestone in the path to clinical availability of the ISCDx test with the recent CLIA active status designation for the Franklin, Ohio laboratory facility. Thi...

NEW YORK (GenomeWeb) – Molecular diagnostics company Ischemia Care has developed a laboratory-developed test, the ISCDx, that it sayscan better determine the cause of strokes based on gene expression analysis, and help clinicians better treat patients

[OXFORD, OHIO, May 8, 2018] - MedCity News and Mid-America Healthcare Investors Network hosted a pitch competition in Chicago. It brought together the best startups across health IT, biopharma, health services, diagnostics and medical device categories. After narrowing...

January 22, 2018 - BASE Clinical Trial data presented at International Stroke Conference in Los Angeles, CA

https://weare.techohio.ohio.gov/2017/09/25/ischemia-care-could-reduce-stroke-deaths/